Efficacy and Safety of Single Doses of Indacaterol Delivered Via a Single Dose Dry Powder Inhaler (SDDPI) Compared to Placebo in Patients With Persistent Asthma

Completed · Phase 2/Phase 3

Conditions studied: Asthma

In brief

The study is designed to obtain safety and efficacy data on three dose levels of indacaterol when delivered via an SDDPI in patients with persistent asthma. All patients will receive 1 day of treatment with each of the following: indacaterol 150 µg, indacaterol 300 µg, indacaterol 600 µg, placebo, and formoterol. Each treatment day will be followed by a washout-period of 1 week

Key facts

Study ID

NCT00403637

Run by

Novartis

People needed

45

Starts

2006-11-01

Expected to finish

2007-02-01

Last updated by the study team

2016-11-18

Who can join

Age: 12 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Males and females 12 - 75 years of age with a diagnosis of persistent asthma
• Daily treatment with a bronchodilator and daily dose of at least 100 µg beclomethasone dipropionate or equivalent
• FEV1 at Visit 1 at least 50% of the predicted normal value
• FEV1 reversibility at least 15%

You may not qualify if…

• Use of tobacco products within 6 months prior to Visit 1 or a smoking history of more than 10 pack years
• Chronic Obstructive Pulmonary Disease (COPD)
• Seasonal allergy where asthma is likely to deteriorate during the period of the study
• Emergency room treatment for an acute asthma attack within the previous 6 weeks or hospitalized within the previous 6 months
• A respiratory tract infection within the previous 6 weeks Other protocol-defined exclusion criteria may apply

Where it is running

• Colorado Allergy and Asthma Centres, P.C. — Denver, Colorado, United States
• Northeast Medical Research Associates, Inc. — North Dartmouth, Massachusetts, United States
• Clinical Research Institute — Minneapolis, Minnesota, United States
• The Clinical Research Center — St Louis, Missouri, United States
• North Carolina Clinical Research — Raleigh, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.